Pak plane crashes with 127 on board, no survivors found

April 20, 2012

crash

Islamabad, April 20: A Pakistani airliner with 127 people on board crashed in bad weather as it came in to land in Islamabad on Friday, scattering wreckage and leaving no sign of survivors.


The Boeing 737, operated by local airline Bhoja Air, was flying to the capital from Pakistan's biggest city and business hub Karachi. It crashed into wheat fields more than 5 miles (about 9 km) from the airport.


Rawal Khan Maitla, director general of Emergency Disaster Management for the Capital Development Authority, said there were no survivors.


TV reports claimed that the black box of the ill-fated aircraft has been found. However, there was no official confirmation on this.


Rescue workers walked through mud at the crash site with flashlights or with the lights of their cellphones looking for passengers' remains. One held up a tattered e-ticket receipt.


Body parts, wallets and eyeglasses lay among wreckage strewn in a small settlement just outside Islamabad.


"It was as if the entire sky had burst into flames," said a resident of the area.


Parts of the aircraft smashed into electricity poles, blanketing the area in darkness, or into houses. There were no reports of casualties on the ground.


Bhoja Air said the airplane crashed during its approach in Islamabad due to bad weather. There was no indication from the government that it could have been the result of foul play.


A man who had been waiting at Islamabad's Benazir Bhutto International Airport for the flight yelled "my two daughters are dead" as tears streamed down his face.


In a state of shock, he then slumped on the floor and sat silently as other relatives of passengers crowded around lists of those on board.


The uncle of the sisters, 18 and 20, said they were supposed to return to Islamabad on Sunday but flew early to see an aunt who is visiting from London.


"We don't even know when or where we will get to see their bodies," said the uncle, Qamar Abbas, who kept mumbling "no, no, no" to himself.


Headed for honeymoon:

When Sajjad Rizvi and Sania Abbas boarded the flight, they were looking forward to their honeymoon in a hill resort near Islamabad. "We had a joint wedding on March 28," said Sania's brother Zeeshan at the airport.


Nearby, relatives of passengers hugged each other and sobbed. One man cried "my kids, my kids".


The last major aviation accident in Pakistan was in July 2010, when a commercial airliner operated by AirBlue with 152 people on board crashed into the hills overlooking Islamabad.


In 2006, a Pakistan International Airlines aircraft crashed near the central city of Multan, killing 45 people.


State television reported that all hospitals in Islamabad and the nearby city of Rawalpindi had been put on high alert after Friday's crash.


At the capital's main hospital, rescue workers brought in remains of the passengers placed under white sheets soaked in blood.


"Two years later the same story is being repeated in my house again," said Nasreen Mubasher, who was at the hospital waiting for the remains of her brother-in-law, who was a passenger. Another brother-in-law died in the AirBlue crash.


As the police struggled to keep order, trying to keep the distraught calm and television cameras away, Mohammad Nasir hoped somehow that his brother's body would be intact despite the horrific force of the crash.


He approached other relatives of passengers and hospital workers. He kept asking "have you seen any whole bodies?"


The Boeing Company said in a statement on its website that it "wishes to extend its profound condolences to the families and friends" of the Bhoja Air passengers.


At Karachi airport, Asim Hashmi complained the airline's counter was shut and he had no way of obtaining information on his aunt and cousin, who were on flight B4-213.


"We don't know anything," he said. "Just pray for the souls of the departed. That is all we can do now."


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 22,2020

Karachi, Jun 22: India-born renowned Pakistani Shia scholar and author Talib Jauhari passed away here after a prolonged illness. He was 80.

Jauhari, who was born on August 27, 1939 in Patna, is survived by his three sons, Dawn News reported on Monday.

He migrated to Pakistan along with his father in 1949, two years after the Partition.

After obtaining early education from his father, he went to Iraq where he studied religion for 10 years under the renowned Shia scholars of that time.

Jauhari, who was on a ventilator in the intensive care unit of a private hospital for the past 15 days, breathed his last on Sunday night.

His son Riaz Jauhari confirmed his death and said that the body has been shifted to Ancholi Imambargah for the funeral prayers, The Express Tribune newspaper quoted his son as saying.

Jauhari was respected among his sect as he was a class fellow of the widely revered scholar Ayatollah Sayyid Ali al-Husayni al-Sistani.

He was also a poet, historian and philosopher and authored many books.

Pakistan Prime Minister Imran Khan has condoled Jauhari's death.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 8,2020

New Delhi, Jan 8: Iran will welcome any peace initiative by India for de-escalating its tensions with the US after the killing of Iranian military commander Qasem Soleimani, the Iranian envoy here said on Wednesday.

His comments come hours after Iran launched missile strikes against two US military bases in Iraq in retaliation to the killing of its top commander General Qassem Soleimani.

"India usually plays a very good role in (maintaining) peace in the world. At the same time, India belongs to this region. We welcome all initiatives from all countries, especially India as a good friend for us, to not allow escalation (of tensions)," Iranian Ambassador to India Ali Chegeni told reporters after a condolence meeting for Solemani at the country's embassy here.

"We are not for war, we are looking for peace and prosperity for everybody in this region. We welcome any Indian initiative or any project that can help peace and prosperity in this world," he said.

On the Iranian attack on US targets in Iraq, Chegeni said his country retaliated under its right to defend.

Amid spiralling US-Iran tensions over the killing of Soleimani, External Affairs Minister S Jaishankar on Sunday had a conversation with his Iranian counterpart Javad Zarif and US Secretary of State Mike Pompeo, voicing India's concerns over the escalation of tensions.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.